Short answer
LIFECORE BIOMEDICAL, INC. DE (LFCR) filed an 8-K current report with the SEC on August 5, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2), Item 2.02 (Results of Operations and Financial Condition). Fiscal second-quarter and six-month results ended June 30, 2026 announced by Lifecore Biomedical.
LIFECORE BIOMEDICAL, INC. DE 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Fiscal second-quarter and six-month results ended June 30, 2026 announced by Lifecore Biomedical
- Investors should review Exhibit 99.1 for revenue, profitability, liquidity and outlook details
Item 7.01 · Regulation FD Disclosure
- Investor presentation posted August 5, 2026, providing shareholders with updated company information
- Exhibit 99.2 contains the substantive presentation materials for investor review
Item EX-99.1 · Exhibit EX-99.1
- Q2 2026 revenue $34.2M, net loss $(6.2)M, and Adjusted EBITDA $8.6M
- 2026 guidance reaffirmed: revenue $120-$125M and Adjusted EBITDA $20.5-$25M
- Liquidity $38.8M at June 2026, including $17.2M cash and $21.6M revolver availability
- Six new Q2 programs and 13 wins over 12 months strengthen future commercial visibility
- Pipeline targets 11 launches in 2027-2028 with estimated $150-$200M incremental peak revenue potential, not risk-adjusted
Item EX-99.2 · Exhibit EX-99.2
- Q2 2026 revenue $34.2M, net loss $6.2M, and Adjusted EBITDA $8.6M, highlighting strong profitability despite GAAP losses
- 2026 guidance reaffirmed: revenue $120M-$125M and Adjusted EBITDA $20.5M-$25M
- Liquidity $38.8M at June 2026, including $17.2M cash and $21.6M revolver availability
- Six new programs signed in Q2, including two commercial-stage programs, with 13 wins over 12 months
- Growth roadmap targets approximately 12% revenue CAGR and over 25% Adjusted EBITDA margins by year-end 2029
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LIFECORE BIOMEDICAL, INC. DE 8-K filings
Get the next LFCR 8-K as it lands
Follow LFCR for push alerts, or ask the research agent what this filing means.